Class information for: |
Basic class information |
| ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
|---|---|---|---|
| 1104 | 9294 | 42.4 | 78% |
Classes in level above (level 3) |
Classes in level below (level 1) |
| ID, lev. below | Publications | Label for level below |
|---|---|---|
| 643 | 3133 | ROLIPRAM//PDE4//PHOSPHODIESTERASE |
| 7816 | 1246 | CELLULAR BIOCHEM SECT//8 CL CAMP//8 CHLORO ADENOSINE |
| 9353 | 1095 | CAPK//CAMP DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT//PATHOCHEM |
| 9989 | 1037 | ADENYLYL CYCLASE//ABT PHARMAZEUT BIOCHEM//P SITE INHIBITOR |
| 10424 | 998 | YC 1//BAY 41 2272//SOLUBLE GUANYLYL CYCLASE |
| 13675 | 757 | GRAVIN//AKAP//A KINASE ANCHORING PROTEIN |
| 15254 | 653 | TYPE II CGMP DEPENDENT PROTEIN KINASE//CGMP DEPENDENT PROTEIN KINASE//CANC MOL BIOL SECT |
| 21032 | 375 | PDE 5 INHIBITION//PDE5//PHOSPHODIESTERASE 5 |
Terms with highest relevance score |
| Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|---|
| 1 | ROLIPRAM | Author keyword | 202 | 56% | 3% | 246 |
| 2 | PHOSPHODIESTERASE | Author keyword | 169 | 32% | 5% | 439 |
| 3 | PDE4 | Author keyword | 158 | 72% | 1% | 125 |
| 4 | PDE10A | Author keyword | 102 | 89% | 1% | 47 |
| 5 | GRAVIN | Author keyword | 77 | 96% | 0% | 24 |
| 6 | YC 1 | Author keyword | 74 | 62% | 1% | 76 |
| 7 | BAY 41 2272 | Author keyword | 64 | 82% | 0% | 37 |
| 8 | PDE4 INHIBITOR | Author keyword | 59 | 71% | 1% | 48 |
| 9 | A KINASE ANCHORING PROTEIN AKAP | Author keyword | 58 | 88% | 0% | 28 |
| 10 | PHOSPHODIESTERASE 4 | Author keyword | 58 | 58% | 1% | 66 |
Web of Science journal categories |
Author Key Words |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
|---|---|---|---|---|---|---|---|
| 1 | ROLIPRAM | 202 | 56% | 3% | 246 | Search ROLIPRAM | Search ROLIPRAM |
| 2 | PHOSPHODIESTERASE | 169 | 32% | 5% | 439 | Search PHOSPHODIESTERASE | Search PHOSPHODIESTERASE |
| 3 | PDE4 | 158 | 72% | 1% | 125 | Search PDE4 | Search PDE4 |
| 4 | PDE10A | 102 | 89% | 1% | 47 | Search PDE10A | Search PDE10A |
| 5 | GRAVIN | 77 | 96% | 0% | 24 | Search GRAVIN | Search GRAVIN |
| 6 | YC 1 | 74 | 62% | 1% | 76 | Search YC+1 | Search YC+1 |
| 7 | BAY 41 2272 | 64 | 82% | 0% | 37 | Search BAY+41+2272 | Search BAY+41+2272 |
| 8 | PDE4 INHIBITOR | 59 | 71% | 1% | 48 | Search PDE4+INHIBITOR | Search PDE4+INHIBITOR |
| 9 | A KINASE ANCHORING PROTEIN AKAP | 58 | 88% | 0% | 28 | Search A+KINASE+ANCHORING+PROTEIN+AKAP | Search A+KINASE+ANCHORING+PROTEIN+AKAP |
| 10 | PHOSPHODIESTERASE 4 | 58 | 58% | 1% | 66 | Search PHOSPHODIESTERASE+4 | Search PHOSPHODIESTERASE+4 |
Key Words Plus |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | CYCLIC NUCLEOTIDE PHOSPHODIESTERASES | 531 | 47% | 9% | 830 |
| 2 | CAMP SPECIFIC PHOSPHODIESTERASE | 386 | 77% | 3% | 261 |
| 3 | AMP SPECIFIC PHOSPHODIESTERASE | 261 | 95% | 1% | 89 |
| 4 | ROLIPRAM | 261 | 66% | 3% | 245 |
| 5 | AMP PHOSPHODIESTERASE | 149 | 64% | 2% | 146 |
| 6 | REGULATORY SUBUNIT RII | 146 | 88% | 1% | 70 |
| 7 | PDE4 INHIBITORS | 130 | 71% | 1% | 104 |
| 8 | NUCLEOTIDE PHOSPHODIESTERASE | 112 | 50% | 2% | 163 |
| 9 | CAMP PHOSPHODIESTERASE | 100 | 53% | 1% | 134 |
| 10 | NUCLEOTIDE PHOSPHODIESTERASES | 95 | 63% | 1% | 95 |
Journals |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | ADVANCES IN CYCLIC NUCLEOTIDE AND PROTEIN PHOSPHORYLATION RESEARCH | 6 | 20% | 0% | 27 |
| 2 | JOURNAL OF CYCLIC NUCLEOTIDE AND PROTEIN PHOSPHORYLATION RESEARCH | 6 | 21% | 0% | 25 |
| 3 | ADVANCES IN SECOND MESSENGER AND PHOSPHOPROTEIN RESEARCH | 4 | 16% | 0% | 25 |
| 4 | ADVANCES IN CYCLIC NUCLEOTIDE RESEARCH | 2 | 19% | 0% | 12 |
| 5 | JOURNAL OF CYCLIC NUCLEOTIDE RESEARCH | 2 | 15% | 0% | 14 |
| 6 | SECOND MESSENGERS AND PHOSPHOPROTEINS | 2 | 18% | 0% | 11 |
Reviews |
| Title | Publ. year | Cit. | Active references | % act. ref. to same field |
|---|---|---|---|---|
| Advances in targeting cyclic nucleotide phosphodiesterases | 2014 | 39 | 244 | 68% |
| Cyclic nucleotide phosphodiesterases: Molecular regulation to clinical use | 2006 | 698 | 246 | 76% |
| Biochemistry and physiology of cyclic nucleotide Phosphocliesterases: Essential components in cyclic nucleotide signaling | 2007 | 471 | 170 | 69% |
| Structure and Regulation of Soluble Guanylate Cyclase | 2012 | 85 | 164 | 77% |
| Cyclic nucleotide phosphodiesterase (PDE) superfamily: A new target for the development of specific therapeutic agents | 2006 | 399 | 334 | 76% |
| Mammalian Cyclic Nucleotide Phosphodiesterases: Molecular Mechanisms and Physiological Functions | 2011 | 122 | 397 | 70% |
| Overview of PDEs and their regulation | 2007 | 265 | 168 | 88% |
| Protein kinases: evolution of dynamic regulatory proteins | 2011 | 157 | 54 | 54% |
| cGMP-Dependent Protein Kinases and cGMP Phosphodiesterases in Nitric Oxide and cGMP Action | 2010 | 210 | 454 | 54% |
| PDE4 cAMP phosphodiesterases: modular enzymes that orchestrate signalling cross-talk, desensitization and compartmentalization | 2003 | 419 | 120 | 87% |
Address terms |
| Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | ABT PHARMAZEUT BIOCHEM | 35 | 89% | 0.2% | 16 |
| 2 | CELLULAR BIOCHEM SECT | 26 | 55% | 0.4% | 33 |
| 3 | PHARMACOMETR PHARMACOKINET | 13 | 71% | 0.1% | 10 |
| 4 | CARDIAC SIGNAL TRANSDUCT CELLULAR BIOL | 10 | 73% | 0.1% | 8 |
| 5 | MOL PHARMACOL GRP | 9 | 15% | 0.6% | 56 |
| 6 | CANC MOL BIOL SECT | 9 | 83% | 0.1% | 5 |
| 7 | INTERDISCIPLINARY STEM CELL PEDIAT | 9 | 83% | 0.1% | 5 |
| 8 | MED FAK MA N1 | 8 | 100% | 0.1% | 5 |
| 9 | PHARMACOL TOXICOL CLIN PHARM | 7 | 41% | 0.1% | 13 |
| 10 | DIPARTIMENTO BIOL PATOL MOL CELLULARE | 6 | 40% | 0.1% | 12 |
Related classes at same level (level 2) |
| Rank | Relatedness score | Related classes |
|---|---|---|
| 1 | 0.0000016137 | CU GNRH//GRP MED PHARMACOL TOXICOL//GRP GYNAECOL ONCOL |
| 2 | 0.0000011447 | NADPH DIAPHORASE//7 NITROINDAZOLE//NEURONAL NITRIC OXIDE SYNTHASE |
| 3 | 0.0000010819 | PROTEIN KINASE CK2//CASEIN KINASE 2//CK2 |
| 4 | 0.0000010783 | CILOSTAZOL//CLIN PHARMACOKINET PHARMACODYNAM METAB//AZECINES |
| 5 | 0.0000008081 | ATRIAL NATRIURETIC PEPTIDE//C TYPE NATRIURETIC PEPTIDE//ATRIAL NATRIURETIC FACTOR |
| 6 | 0.0000007729 | NITRATE TOLERANCE//NITROGLYCERIN//ORGANIC NITRATES |
| 7 | 0.0000007168 | FARNESYLTRANSFERASE//PALMITOYLATION//RLIP76 |
| 8 | 0.0000006742 | COFFIN LOWRY SYNDROME//ERK5//JNK |
| 9 | 0.0000006597 | LEVOSIMENDAN//CALCIUM SENSITIZERS//CALCIUM SENSITIZER |
| 10 | 0.0000006566 | CHLOROETHYLCLONIDINE//ALPHA1 ADRENOCEPTOR SUBTYPE//BETA3 ADRENOCEPTORS |